Related Experiment Video
Updated: Jun 8, 2026
06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
Current strategies for myocardial gene delivery
Michael G Katz1, JaBaris D Swain, Catherine E Tomasulo
1Department of Surgery, Division of Cardiovascular Surgery, The University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA .
Journal of Molecular and Cellular Cardiology
|September 15, 2010
Summary
Current cardiac gene delivery methods vary in efficacy and safety. The ideal technique offers low morbidity, enhanced myocardial transduction, and minimized systemic vector exposure for effective cardiovascular gene therapy.
Area of Science:
- Cardiovascular Research
- Gene Therapy
- Medical Technology
Background:
- Cardiac gene delivery methods are crucial for treating cardiovascular diseases.
- Existing techniques face challenges including limited transduction efficiency, systemic vector spread, and inflammatory responses.
Purpose of the Study:
- To review and assess current cardiac gene delivery methods.
- To identify criteria for optimal gene delivery strategies in the heart.
Main Methods:
- Categorization of gene delivery methods by injection site, approach, and circulation type.
- Evaluation of efficacy based on myocardial transduction, complexity, and immune response.
Main Results:
- Direct injection methods provide focal delivery but cause systemic exposure.
- Intracoronary infusion is minimally invasive but shows variable efficiency and short residence time.
- Surgical techniques offer potential but involve complexity and morbidity.
Conclusions:
- The optimal cardiac gene delivery technique requires low morbidity and enhanced myocardial targeting.
- Minimizing extracardiac expression and immune response is critical for clinical translation.
